IDXX Idexx Laboratories Inc IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES Best Diagnostics Stocks 2026 →

Idexx Laboratories (IDXX) Stock: Buy, Sell, or Hold?

$702.59
+5.95 (+0.85%) ▲
5d: +0.58% 30d: +35.03% 90d: +23.93%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (35%)
Quality Score
32/100
Position
EXTENDED
30-Day Fair Range
$517.15 – $652.26
Position: EXTENDED
Forward P/E & Valuation
41.6x FAIR
vs 36.9x historical avg
Wall Street Target
$717.17
+2.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$540.61 / $713.74
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: IDXX shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When IDXX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$627.59
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$389.68
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: IDXX is currently trading at $702.59, which is considered extended relative to its 30-day fair value range of $517.15 to $652.26. From a valuation perspective, the stock is trading at a premium (Forward PE: 41.6) compared to its historical average (36.9). At these levels, the market is pricing in 4.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, IDXX is in a uptrend. The price is approaching resistance at $713.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: IDXX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $517.15 - $652.26
Company Quality Score 32/100 (SELL)
Volume Confirmation HIGH
Confidence Score 35.4%

Trading Range & Key Levels

30-Day Trading Range $517.15 - $652.26
Current vs Trading Range EXTENDED
Expected Move (7 Days) ±$31.49 (4.5%)
Support Level $540.61
Resistance Level $713.74
Current Trend Uptrend
Technical data as of Nov 11, 2026

Protect Your Profits

IDXX is technically overbought (RSI 72). Consider hedging now to protect against a potential pullback while keeping your upside.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BEARISH: Price extended above range (+7.7% above its trading range)
  • BULLISH: Options cheap (IV 0th percentile)
  • BEARISH: Weak technical setup (0/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($717.17)
  • NEUTRAL: Market pricing in 4.1% annual earnings growth - fairly valued
  • WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 41.62
Wall Street Target $717.17 (+2.1%)
Revenue Growth (YoY) 9.9%
Earnings Growth (YoY) 17.9%
Profit Margin 25.4%
Valuation Premium vs History +4.1% premium
PE vs Historical 41.6 vs 36.9 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +4.1% (market-implied from PE analysis)
1-Year Target $731.40 (+4%)
2-Year Target $761.38 (+8%)
3-Year Target $792.60 (+13%)
3-Yr Target (if PE normalizes) (PE: 42→37) PE COMPRESSION $702.79 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 41.6, Growth: 12.6%) $1001.95 (+43%)
Base: (SPY PE: 19.9, Growth: 12.6%) $478.16 (-32%)
Bear: (PE: 16.9, Growth: 12.6%) $406.43 (-42%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (47x PE), but valuation improves significantly next year (42x PE) as earnings recover.
Trailing PE: 46.94 | Current EPS (TTM): $14.84
Bull Case $871.79 (+24%)
Analyst growth 13.8%, PE expands to 51.6
Base Case $792.54 (+13%)
Market implied 13.8%, PE stable at 46.9
Bear Case $473.72 (-33%)
Severe decline -20.0%, PE contracts to 39.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share IDXX Analysis

Share this live IDXX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (IDXX)

Bullish 3 Retail Mentions
Reddit / WSB Comments
2
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 7, 2026
Daily AI digest
AI Retail Discussion Summary: Bullish sentiment on StockTwits regarding pet stocks, specifically mentioning $IDXX, with no bearish or neutral sentiment detected. The latest Yahoo Finance news article focuses on the upcoming earnings reports for various companies, including $IDXX, but does not provide specific bullish or bearish analysis.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:48 AM ET
Data refreshes hourly during market hours. Next update: 8:48 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for IDXX.

Create Free Account

Already have an account? Log In

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
GH
Guardant Health Inc
STRONG BUY
26 analysts
$201 51 HOLD
NTRA
Natera Inc
STRONG BUY
23 analysts
$416 65 BUY
EXAS
EXACT Sciences Corporati…
STRONG BUY
26 analysts
$106 52 HOLD
TMO
Thermo Fisher Scientific…
STRONG BUY
27 analysts
$752 47 HOLD
DHR
Danaher Corporation
STRONG BUY
24 analysts
$260 51 HOLD

Advanced IDXX Option Strategies

Professional options setups generated by AI based on today's IDXX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive IDXX Research Pages
IDXX Technical Chart IDXX Price Prediction IDXX Intrinsic Value DCF IDXX Earnings Date IDXX Investment Advisor IDXX Fair Price Analyzer IDXX Options Chain IDXX Options Advisor IDXX Options Analysis IDXX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals